#DNA

Watch these videos to learn how the Prostate Cancer Promise registry aims to identify hereditary DNA mutations.

“This is simply a blood draw.” Analyzing plasma to define gene mutations in breast cancer is less invasive than tissue biopsies.

The technology used to create COVID-19 vaccines may also help fight cancer.

Researchers created a new type of cancer drug that causes lethal DNA damage in the cells of brain tumors called glioblastomas.

A new approach to prognosis looks to patients’ genomes for clues about how their cancer will behave.

Genomic tumor profiling in pediatric patients can clarify diagnosis and treatment, a recent study found.

Artificial intelligence and machine learning can help identify genetic changes that lead to cancer—and which treatments work best.

A new study is investigating the genetic differences that leave Black men more susceptible to prostate cancer.

Researchers developed a new tool, the EPIC-seq, that can diagnose cancer subtypes from patient blood samples.

Around 20% to 30% of meningiomas are aggressive and potentially deadly.

In a small trial, Jemperli led to complete remission in people with a biomarker for deficient DNA repair.

Researchers hope to easily identify which colon cancer patients are unlikely to benefit from immune checkpoint inhibitors (ICIs).

There’s big news about metabolism from recent study findings that is shaking up our understanding of how metabolism changes with age.

When physicians include stool-based testing as an option to patients who don’t want colonoscopies, colorectal cancer screening rates go up.

Damon Runyon Cancer Research Foundation Fellows are mapping the genetics of DNA repair, with implications for cancer research.

It is difficult, if not impossible, to imprint on others the what-it’s-likeness of cancer, in my case, brain cancer.